Exercise intensity and cardiac disease development in carriers of titin variants

12 May 2024 (10:12 - 10:21)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Giulio Savonitto

Karolinska Institutet, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail

Sex-differences from referral to tafamidis treatment outcomes in real-world patients with wild-type transthyretin amyloid cardiomyopathy.

Doctor P. Debonnaire (Brugge, BE)

Abstract Slides Video

Presentation thumbnail

Prevalence and prognostic implications of right ventricular systolic dysfunction and reverse remodeling in dilated cardiomyopathy: a longitudinal prospective cardiac magnetic resonance investigation

Doctor E. Dziewiecka (Krakow, PL)

Abstract Slides Video

Presentation thumbnail

Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy

Doctor M. Setti (Verona, IT)

Abstract Slides Video

Presentation thumbnail

Cardiac magnetic resonance and genetics: an integrated approach to predict left ventricular reverse remodeling in dilated cardiomyopathy

Doctor M. Iseppi (Trento, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Evaluation of prognosis in cardiomyopathies

The Event

Event poster

Heart Failure 2024

12 May 2024 10:12 CET

You may be interested in

Congress Presentation

Exercise intensity and cardiac disease development in carriers of titin variants

4 April 2025

Congress Session

Modern technologies in heart failure

21 May 2022

Congress Presentation

Beyond restrictions: exercise guidance in primary arrhythmia syndromes

12 April 2026

Congress Session

Sports Cardiology and Exercise 2

14 April 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources